Nano-X Imaging (NNOX) EBITDA (2019 - 2026)

Nano-X Imaging (NNOX) has reported EBITDA for 8 consecutive years, with -$14.6 million the latest figure, recorded in Q1 2026.

• Quarterly EBITDA fell 3.32% year-over-year to -$14.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$78.4 million (down 35.85% YoY) and the FY2025 annual result came in at -$78.2 million, down 37.87% from the prior year.
• EBITDA climbed to -$14.6 million in Q1 2026 per NNOX's latest filing, from -$35.4 million in the prior quarter.
• Over the last five years, EBITDA for NNOX reached as high as -$10.7 million in Q4 2023 and fell as low as -$53.8 million in Q4 2022.
• A 5-year average of -$19.4 million and a median of -$14.6 million in 2026 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2022 — EBITDA plunged 145.29% — and 2023, when it soared 80.12%.
• Year by year, EBITDA stood at -$53.8 million in 2022, then surged by 80.12% to -$10.7 million in 2023, then tumbled by 40.12% to -$15.0 million in 2024, then sank by 136.51% to -$35.4 million in 2025, then soared by 58.9% to -$14.6 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$14.6 million, -$35.4 million, and -$14.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.